RWC Asset Management LLP
Source: SEC Form 13F · as of Mar 2026RWC Asset Management LLP holds 15 biotech & pharma companies tracked by BioSniper, totaling $171.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$171.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 257,155 | $62.9M |
| BAXBaxter International Inc. | 3,077,569 | $51.7M |
| PMPhilip Morris International Inc | 174,315 | $28.8M |
| MRKMerck & Co., Inc. | 205,090 | $24.7M |
| LLYELI LILLY & Co | 772 | $710K |
| ABBVAbbVie Inc. | 3,126 | $680K |
| SYRESpyre Therapeutics, Inc. | 8,166 | $412K |
| DNTHDianthus Therapeutics, Inc. /DE/ | 4,646 | $390K |
| GHGuardant Health Inc. | 3,866 | $357K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 856 | $232K |
| ABTABBOTT LABORATORIES | 2,238 | $230K |
| CGONCG Oncology, Inc. | 3,295 | $223K |
| SRRKScholar Rock Holding Corp | 4,504 | $221K |
| MIRMMirum Pharmaceuticals, Inc. | 2,341 | $216K |
| IQVIQVIA Holdings Inc. | 1,266 | $216K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.